Literature DB >> 34226589

Bone mineral density response prediction following osteoporosis treatment using machine learning to aid personalized therapy.

Thiraphat Tanphiriyakun1,2, Sattaya Rojanasthien1, Piyapong Khumrin3,4.   

Abstract

Osteoporosis is a global health problem for ageing populations. The goals of osteoporosis treatment are to improve bone mineral density (BMD) and prevent fractures. One major obstacle that remains a great challenge to achieve the goals is how to select the best treatment regimen for individual patients. We developed a computational model from 8981 clinical variables, including demographic data, diagnoses, laboratory results, medications, and initial BMD results, taken from 10-year period of electronic medical records to predict BMD response after treatment. We trained 7 machine learning models with 13,562 osteoporosis treatment instances [comprising 5080 (37.46%) inadequate treatment responses and 8482 (62.54%) adequate responses] and selected the best model (Random Forests with area under the receiver operating curve of 0.70, accuracy of 0.69, precision of 0.70, and recall of 0.89) to individually predict treatment responses of 11 therapeutic regimens, then selected the best predicted regimen to compare with the actual regimen. The results showed that the average treatment response of the recommended regimens was 9.54% higher than the actual regimens. In summary, our novel approach using a machine learning-based decision support system is capable of predicting BMD response after osteoporosis treatment and personalising the most appropriate treatment regimen for an individual patient.

Entities:  

Year:  2021        PMID: 34226589     DOI: 10.1038/s41598-021-93152-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  30 in total

1.  Management of glucocorticoid-induced osteoporosis: What is new?

Authors:  Juliet Compston
Journal:  Int J Rheum Dis       Date:  2019-09       Impact factor: 2.454

2.  Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.

Authors:  Marc C Hochberg; Susan Greenspan; Richard D Wasnich; Paul Miller; Desmond E Thompson; Philip D Ross
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

3.  Mortality after osteoporotic fractures.

Authors:  O Johnell; J A Kanis; A Odén; I Sernbo; I Redlund-Johnell; C Petterson; C De Laet; B Jönsson
Journal:  Osteoporos Int       Date:  2003-10-30       Impact factor: 4.507

4.  Bone mineral density is a predictor of survival.

Authors:  C Johansson; D Black; O Johnell; A Odén; D Mellström
Journal:  Calcif Tissue Int       Date:  1998-09       Impact factor: 4.333

5.  Treatment failure in osteoporosis.

Authors:  A Diez-Perez; J D Adachi; D Agnusdei; J P Bilezikian; J E Compston; S R Cummings; R Eastell; E F Eriksen; J Gonzalez-Macias; U A Liberman; D A Wahl; E Seeman; J A Kanis; C Cooper
Journal:  Osteoporos Int       Date:  2012-07-27       Impact factor: 4.507

6.  Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses.

Authors:  P D Delmas; Zhengqing Li; Cyrus Cooper
Journal:  J Bone Miner Res       Date:  2003-12-16       Impact factor: 6.741

7.  Osteoporosis care at risk in the United States.

Authors:  E M Lewiecki; S Baim; E S Siris
Journal:  Osteoporos Int       Date:  2008-08-29       Impact factor: 4.507

8.  Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis.

Authors:  Steven R Cummings; Felicia Cosman; E Michael Lewiecki; John T Schousboe; Douglas C Bauer; Dennis M Black; Thomas D Brown; Angela M Cheung; Kathleen Cody; Cyrus Cooper; Adolfo Diez-Perez; Richard Eastell; Peyman Hadji; Takayuki Hosoi; Suzanne Jan De Beur; Risa Kagan; Douglas P Kiel; Ian R Reid; Daniel H Solomon; Susan Randall
Journal:  J Bone Miner Res       Date:  2016-12-27       Impact factor: 6.741

9.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

Review 10.  Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis.

Authors:  T Songpatanasilp; C Sritara; W Kittisomprayoonkul; S Chaiumnuay; H Nimitphong; N Charatcharoenwitthaya; C Pongchaiyakul; S Namwongphrom; T Kitumnuaypong; W Srikam; P Dajpratham; V Kuptniratsaikul; U Jaisamrarn; K Tachatraisak; S Rojanasthien; P Damrongwanich; W Wajanavisit; S Pongprapai; B Ongphiphadhanakul; N Taechakraichana
Journal:  Osteoporos Sarcopenia       Date:  2016-12-10
View more
  2 in total

1.  Development and internal validation of a machine-learning-developed model for predicting 1-year mortality after fragility hip fracture.

Authors:  Nitchanant Kitcharanant; Pojchong Chotiyarnwong; Thiraphat Tanphiriyakun; Ekasame Vanitcharoenkul; Chantas Mahaisavariya; Wichian Boonyaprapa; Aasis Unnanuntana
Journal:  BMC Geriatr       Date:  2022-05-24       Impact factor: 4.070

2.  Osteoporosis in 10 years time: a glimpse into the future of osteoporosis.

Authors:  Giovanni Adami; Angelo Fassio; Davide Gatti; Ombretta Viapiana; Camilla Benini; Maria I Danila; Kenneth G Saag; Maurizio Rossini
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-03-20       Impact factor: 5.346

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.